1. U.S. Food and Drug Administration. Draft guidance for industry: metered dose inhaler (MDI) and dry powder inhaler (DPI) drug products. 1998.
2. U.S. Food and Drug Administration. Guidance for industry: nasal spray and inhalation solution, suspension, and spray drug products—chemistry, manufacturing, and controls documentation. 2002.
3. U.S. Food and Drug Administration. Draft guidance for industry: bioavailability and bioequivalence studies for nasal aerosols and nasal sprays for local action. 2003.
4. Guo C, Doub WH. Development of a novel technology to measure impaction force of nasal sprays and metered dose inhalers using the texture analyser. In: Byron PR, Peart J, Suman JD, Farr SJ, Dalby RN, editors. Respiratory drug delivery. River Grove: Davis Healthcare International Publishing; 2006. p. 621–4.
5. Guo C, Ye W, Kauffman JF, Doub WH. Evaluation of impaction force of nasal sprays and metered-dose inhalers using the texture analyser. J Pharm Sci. 2009;98(8):2799–806.